GlassScriptPhysician profile
Mark D Barros
NPI 1760586440
$1,644.37
in general payments reported to CMS, 2019-2025
10 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $510 · 2022: $397 · 2023: $332 · 2024: $239 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $447.48 | 2021-2023 | Endurant Iis |
| Cardiovascular Systems INC. | $418.59 | 2021-2022 | |
| Abbott Laboratories | $205.98 | 2021-2025 | Esprit, Jeti, Acculink |
| Philips North America LLC | $201.97 | 2023-2025 | (Bh4) Igt Devices Undivided, Igt Devices Systems Undivided, (Bs1) Peripheral Vascular Undivided |
| Shockwave Medical, INC | $95.68 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $78.11 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Getinge USA Sales, LLC | $64.16 | 2021-2023 | Fusion Bioline Supported Vascular Grafts |
| Veryan Medical Incorporated | $64.15 | 2025 | Biomimics 3d Vascular Stent System |
| Pfizer INC. | $50.39 | 2021-2025 | |
| W. L. Gore & Associates, INC. | $17.86 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Barros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.